Search

Search Constraints

You searched for: Author/Creator Suzuki, Michihiro

Search Results

2. Daclatasvir and asunaprevir improves health‐related quality of life in Japanese patients infected with hepatitis C virus. Issue 3 (14th May 2018)

3. Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment. (10th October 2018)

5. Efficacy of ledipasvir/sofosbuvir with or without ribavirin for 12 weeks in genotype 1b HCV patients previously treated with a nonstructural protein 5A inhibitor‐containing regimen. Issue 10 (4th May 2018)

6. Field practice study of half‐dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis. Issue 3 (28th May 2014)

7. Field practice study of half‐dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis. Issue 3 (28th May 2014)

8. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score‐based weighting. Issue 3 (March 2015)

9. Impact of resistance‐associated variant dominancy on treatment in patients with HCV genotype 1b receiving daclatasvir/asunaprevir. Issue 1 (6th July 2016)

10. Prediction of esophagogastric varices associated with oxaliplatin administration. Issue 11 (2nd November 2021)